scPharmaceuticals Inc. (SCPH)
USD 2.58
(11.21%)
USD 2.58
(11.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -59.24 Million | -34.57 Million | -27.15 Million | -27.69 Million | -30.44 Million | -28.81 Million |
| Net Income | -54.81 Million | -36.83 Million | -28.03 Million | -32.2 Million | -32.99 Million | -29.44 Million |
| Depreciation & Amortization | 626 Thousand | 468 Thousand | 438 Thousand | 399 Thousand | 364 Thousand | 332 Thousand |
| Deferred income taxes | 6.54 Million | - | - | 30 Thousand | 2000.00 | - |
| Stock-based compensation | 4.85 Million | 2.83 Million | 2.36 Million | 2 Million | 1.44 Million | 2.13 Million |
| Change in working capital | -6.32 Million | -350 Thousand | -2.59 Million | 1.44 Million | 354 Thousand | -2.21 Million |
| Other non-cash items | -10.13 Million | -695 Thousand | 678 Thousand | 639 Thousand | 385 Thousand | 374 Thousand |
| Investing Cash Flow | 19.96 Million | -45.85 Million | 32.13 Million | -33.46 Million | - | - |
| Investments in PPE | -40 Thousand | -21 Thousand | -9000.00 | - | - | - |
| Acquisitions | - | 45.83 Million | -32.13 Million | - | - | - |
| Investment purchases | -50.59 Million | -67.53 Million | -9.01 Million | -72.16 Million | - | - |
| Sales/Maturities of investments | 70.6 Million | 21.7 Million | 41.15 Million | 38.7 Million | - | - |
| Other Investing Activities | 20 Million | -45.83 Million | 32.13 Million | -33.46 Million | - | - |
| Financing Cash Flow | 14.85 Million | 77.22 Million | -2.53 Million | 60.34 Million | 13.58 Million | -8000.00 |
| Debt repayment | - | -17.5 Million | -2.5 Million | - | -9.55 Million | -62 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -54 Thousand | -81 Thousand | -164 Thousand | - | -4000.00 |
| Common Stock Issuance | 14.85 Million | 47.76 Million | 51 Thousand | 60.57 Million | 3.97 Million | 54 Thousand |
| Other Financing Activities | 14.85 Million | 47.07 Million | -81 Thousand | -64 Thousand | 19.17 Million | 58 Thousand |
| Accounts receivables | -4.48 Million | - | - | - | - | - |
| Accounts payables | 5.55 Million | 1.76 Million | -2.36 Million | 1.21 Million | 965 Thousand | -1.37 Million |
| Inventory | -7.6 Million | -1.23 Million | - | - | - | - |
| Other working capital | 221 Thousand | -887 Thousand | -234 Thousand | 236 Thousand | -611 Thousand | -833 Thousand |
| Cash at beginning of period | 71.24 Million | 74.45 Million | 72 Million | 72.8 Million | 89.66 Million | 118.48 Million |
| Cash at end of period | 46.81 Million | 71.24 Million | 74.45 Million | 72 Million | 72.8 Million | 89.66 Million |
| Capital Expenditure | -40 Thousand | -21 Thousand | -9000.00 | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -24.42 Million | -3.2 Million | 2.44 Million | -805 Thousand | -16.85 Million | -28.82 Million |
| Free Cash Flow | -59.28 Million | -34.59 Million | -27.16 Million | -27.69 Million | -30.44 Million | -28.81 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -17.09 Million | -14.1 Million | -13.81 Million | -54.81 Million | -15.63 Million | -14.15 Million |
| Depreciation & Amortization | 52 Thousand | 51 Thousand | 140 Thousand | 626 Thousand | 272 Thousand | 109 Thousand |
| Deferred income taxes | - | - | -1.56 Million | 6.54 Million | -663 Thousand | -597 Thousand |
| Stock-based compensation | 1.49 Million | 1.44 Million | 1.41 Million | 4.85 Million | 1.28 Million | 1.17 Million |
| Change in working capital | -6.46 Million | -2.48 Million | -515 Thousand | -6.32 Million | 734 Thousand | -1.2 Million |
| Other non-cash items | 8.92 Million | 1.84 Million | -822 Thousand | -10.13 Million | 559 Thousand | 524 Thousand |
| Investing Cash Flow | 1000.00 | 29.31 Million | 26.46 Million | 19.96 Million | -22.92 Million | 9.42 Million |
| Investments in PPE | - | - | -37 Thousand | -40 Thousand | - | -3000.00 |
| Acquisitions | - | - | 9.43 Million | - | - | -9.43 Million |
| Investment purchases | - | - | - | -50.59 Million | -38.92 Million | -11.67 Million |
| Sales/Maturities of investments | 1000.00 | 29.31 Million | 26.5 Million | 70.6 Million | 16 Million | 21.1 Million |
| Other Investing Activities | 1000.00 | 29.31 Million | 26.5 Million | 20 Million | -22.92 Million | 9.43 Million |
| Financing Cash Flow | 283 Thousand | 15 Thousand | 467 Thousand | 14.85 Million | 68 Thousand | 611 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 5.54 Billion | -166 Thousand | -9.45 Billion | - | 4.72 Billion | 4.73 Billion |
| Common Stock Issuance | 283 Thousand | 181 Thousand | 812 Thousand | 14.85 Million | - | 334 Thousand |
| Other Financing Activities | 283 Thousand | -166 Thousand | 467 Thousand | 14.85 Million | 68 Thousand | 611 Thousand |
| Accounts receivables | -344 Thousand | -1.28 Million | -314 Thousand | -4.48 Million | -2.56 Million | 1.39 Million |
| Accounts payables | 560 Thousand | -862 Thousand | 2.16 Million | 5.55 Million | 4.17 Million | -1.1 Million |
| Inventory | -5.76 Million | -758 Thousand | -1.71 Million | -7.6 Million | -1.29 Million | -2.21 Million |
| Other working capital | -917 Thousand | 422 Thousand | -646 Thousand | 221 Thousand | 411 Thousand | 717 Thousand |
| Cash at beginning of period | 58.44 Million | 46.81 Million | 35.04 Million | 71.24 Million | 71.35 Million | 75.45 Million |
| Cash at end of period | 38.5 Million | 58.44 Million | 46.81 Million | 46.81 Million | 35.04 Million | 71.35 Million |
| Capital Expenditure | - | - | -37 Thousand | -40 Thousand | - | -3000.00 |
| Effect of forex changes on cash | - | - | -345 Thousand | - | 4.75 Billion | 4.73 Billion |
| Net cash flow / Change in cash | -19.94 Million | 11.63 Million | 11.77 Million | -24.42 Million | -36.3 Million | -4.1 Million |
| Free Cash Flow | -20.22 Million | -17.7 Million | -15.19 Million | -59.28 Million | -13.45 Million | -14.14 Million |
PCPDF
HRB
347850
000521
CWV
PREKF